ArticleToxicology reports2022
Exposure assessment and cancer risk characterization of aflatoxin M
Article in Toxicology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Review
- The health risk assessment and determination of aflatoxin MFood chemistry: X · 2026Article
- Mapping Global Research Trends on Aflatoxin M1 in Dairy Products: An Integrative Review of Prevalence, Toxicology, and Control Approaches.Foods (Basel, Switzerland) · 2026Review
- The economic crisis in Lebanon and adolescent nutritional health: a multi-mycotoxin exposure and risk assessment of stunting and thinness.Frontiers in nutrition · 2026Article
- Monitoring Aflatoxin M1 in Milk From Selected Iranian Provinces Using Different Assays: Seasonal Trends and Processing Effects.Food science & nutrition · 2025Article
- Impact of Aflatoxins on the Digestive, Immune, and Nervous Systems: The Role of Microbiota and Probiotics in Toxicity Protection.International journal of molecular sciences · 2025Review
- Occurrence of Aflatoxin M1 over Three Years in Raw Milk from Croatia: Exposure Assessment and Risk Characterization in Consumers of Different Ages and Genders.Foods (Basel, Switzerland) · 2025Article
- First Total Diet Study of Aflatoxins in Singapore: Exposure Risk, High-Risk Foods, and Public Health Implications.Toxins · 2025Article
- Occurrence of Aflatoxin MToxins · 2025Article
- Health risks evaluation of mycotoxins in plant-based supplements marketed in Malaysia.Scientific reports · 2025Article
- Fungal profile, levels of aflatoxin M1, exposure, and the risk characterization of local cheese 'Toxicology reports · 2024Article
- Risk of exposure to aflatoxin M1 through consumption of cow's milk among children in Magadu, Morogoro.Mycotoxin research · 2024Article
- Assessment of Human Health Risks from Aflatoxin M1 in Raw Milk: A Study from North Shewa Zone, Oromia Region, Ethiopia.Environmental health insights · 2024Article
- Article
- Survey of knowledge, and attitudes to storage practices preempting the occurrence of filamentous fungi and mycotoxins in some Ghanaian staple foods and processed products.Scientific reports · 2023Article
- Exposure and Health Risk Assessment of Aflatoxin MFoods (Basel, Switzerland) · 2023Article
- Occurrence of Aflatoxin M1 in Cow, Goat, Buffalo, Camel, and Yak Milk in China in 2016.Toxins · 2022Article
- Occurrence of Aflatoxin M1 in Three Types of Milk from Xinjiang, China, and the Risk of Exposure for Milk Consumers in Different Age-Sex Groups.Foods (Basel, Switzerland) · 2022Article
- Probabilistic modeling and risk characterization of the chronic aflatoxin M1 exposure of Hungarian consumers.Frontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Milk and dairy products are the most important nutritional foods among all age groups. Aflatoxin M1 (AFM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.